VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 13 filers reported holding VISTAGEN THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,996 | +21.1% | 16,000 | 0.0% | 0.00% | – |
| Q4 2022 | $1,648 | -17.6% | 16,000 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $2,000 | -85.7% | 16,000 | 0.0% | 0.00% | -75.0% |
| Q2 2022 | $14,000 | -30.0% | 16,000 | 0.0% | 0.00% | -20.0% |
| Q1 2022 | $20,000 | -35.5% | 16,000 | 0.0% | 0.01% | -28.6% |
| Q4 2021 | $31,000 | -29.5% | 16,000 | 0.0% | 0.01% | -36.4% |
| Q3 2021 | $44,000 | -12.0% | 16,000 | 0.0% | 0.01% | -8.3% |
| Q2 2021 | $50,000 | +47.1% | 16,000 | 0.0% | 0.01% | +50.0% |
| Q1 2021 | $34,000 | +9.7% | 16,000 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $31,000 | +181.8% | 16,000 | 0.0% | 0.01% | +166.7% |
| Q3 2020 | $11,000 | +37.5% | 16,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $8,000 | +14.3% | 16,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $7,000 | -36.4% | 16,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $11,000 | -35.3% | 16,000 | 0.0% | 0.00% | -50.0% |
| Q3 2019 | $17,000 | +41.7% | 16,000 | 0.0% | 0.01% | +50.0% |
| Q2 2019 | $12,000 | -33.3% | 16,000 | +14.3% | 0.00% | -33.3% |
| Q1 2019 | $18,000 | +1700.0% | 14,000 | +976.9% | 0.01% | – |
| Q4 2017 | $1,000 | -50.0% | 1,300 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $2,000 | 0.0% | 1,300 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $2,000 | 0.0% | 1,300 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $2,000 | -60.0% | 1,300 | 0.0% | 0.00% | -66.7% |
| Q4 2016 | $5,000 | 0.0% | 1,300 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $5,000 | +25.0% | 1,300 | +18.2% | 0.00% | +50.0% |
| Q2 2016 | $4,000 | – | 1,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|